首页> 外文期刊>European Heart Journal - Case Reports >The efficiency of exercise stress echocardiography for evaluating symptomatic mitral regurgitation
【24h】

The efficiency of exercise stress echocardiography for evaluating symptomatic mitral regurgitation

机译:运动应激超声心动图评估症状二尖瓣反流性的效率

获取原文
           

摘要

We report a case of symptomatic mitral regurgitation with systolic anterior motion (SAM-MR) evaluated by exercise stress echocardiography (ESE), which was successfully treated with MitraClipTM (Abbott Medical, Abbott Park, IL, USA). A 76-year-old woman with a history of hypertrophic obstructive cardiomyopathy had exertional dyspnoea despite medical therapy (5 mg dose of amlodipine and bisoprolol) and was admitted to our hospital due to heart failure. The echocardiogram showed a moderate-to-severe MR with an effective regurgitant orifice area of 0.37 cm2 and a regurgitant volume of 69 mL/s (Video 1). A left ventricular outflow tract (LVOT) obstruction was observed. ESE showed an elevated post-exercise LVOT gradient [rest 4.27 m/s (Figure 1, Panels A-1 and A-3), during-exercise 6.19 m/s (Figure 1, Panels A-2 and A-4)] and pulmonary hypertension (PH) assessed by estimated systolic pulmonary artery pressure. The use of a MitraClipTM improved her condition (New York Heart Association class changed from III to I) Postprocedural transoesophageal echocardiogram showed no residual MR and mean mitral valve pressure gradient was 3.9mmHg (Video 2). Three months later, ESE showed improvement in exercise-induced PH, MR, and LVOT obstruction [rest 1.33 m/s (Figure 1, Panels B-1 and B-3), during-exercise 1.53 m/s (Figure 1, Panels B-2 and B-4)]. ESE showed some exertion symptoms that were not evaluated by resting echocardiology. ESE is a potentially useful tool to assess the improvement of SAM-MR following MitraClipTM therapy.
机译:我们报告了通过运动应激超声心动图(ESE)评估的收缩前运动(SAM-MR)进行了症状二尖瓣反冲的情况,该出现应激超声心动图(ESE)成功地用MitraCliptm(雅培医疗,雅培公园,IL,USA)。尽管有医疗治疗(5毫克氨氯地脂剂量的氨水脂和Bisoprolol),这是一个76岁的女性患有肥厚性阻塞性心肌病的历史,并且由于心力衰竭,我们的医院被录取。超声心动图显示了具有0.37cm 2的有效反流孔面积的中度至严重的MR,其重新注射体积为69mL / s(视频1)。观察到左心室流出道(LVOT)梗阻。 ESE显示出锻炼后升高的LVOT梯度[休息4.27 m / s(图1,面板A-1和A-3),运动期间6.19 m / s(图1,面板A-2和A-4)]通过估计的收缩期肺动脉压评估的肺动脉高压(pH)。使用Mitracliptm改善了她的病情(纽约心脏关联类从III转到I)后,后期转基因超声心动图显示没有残留的MR和平均二尖瓣压梯度为3.9mmHg(视频2)。三个月后,ESE在运动诱导的pH,MR和LVOT障碍方面表现出改善[休息1.33 m / s(图1,面板B-1和B-3),运动1.53 m / s期间(图1,面板B-2和B-4)]。 ESE显示出一些不通过休息超声病理学评估的施用症状。 ESE是评估Mitrocliptm治疗后SAM-MR的改善的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号